High prevalence of methotrexate intolerance in rheumatoid arthritis patients: a cross-sectional study
Abstract Background Methotrexate (MTX) is the most commonly used disease-modifying antirheumatic drug (DMARD) for treating rheumatoid arthritis (RA). However, MTX use is associated with gastrointestinal adverse effects in a number of patients. Early detection of MTX intolerance could help modify the...
Tallennettuna:
| Päätekijät: | , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2025-07-01
|
| Sarja: | BMC Rheumatology |
| Aiheet: | |
| Linkit: | https://doi.org/10.1186/s41927-025-00466-2 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|